TY - JOUR
T1 - Cytokeratin staining for primary and metastatic colorectal cancer
AU - Kummar, Shivaani
AU - Ciesielski, Thomas E.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001/11
Y1 - 2001/11
N2 - Determining the site of origin of metastatic adenocarcinoma lesions has obvious therapeutic and prognostic implications. Immunostaining for cytokeratin subtypes 7 and 20 is increasingly used to evaluate metastatic colorectal cancer lesions. We present the case of a patient with a history of colorectal cancer who subsequently developed an isolated metastatic lesion in the lung. As illustrated by our case, staining for cytokeratin subtypes can be helpful in determining the site of origin of metastatic lesions.
AB - Determining the site of origin of metastatic adenocarcinoma lesions has obvious therapeutic and prognostic implications. Immunostaining for cytokeratin subtypes 7 and 20 is increasingly used to evaluate metastatic colorectal cancer lesions. We present the case of a patient with a history of colorectal cancer who subsequently developed an isolated metastatic lesion in the lung. As illustrated by our case, staining for cytokeratin subtypes can be helpful in determining the site of origin of metastatic lesions.
KW - Colorectal cancer
KW - Cytokeratin staining
KW - Metastatic adenocarcinoma
UR - http://www.scopus.com/inward/record.url?scp=0035522655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035522655&partnerID=8YFLogxK
U2 - 10.3816/CCC.2001.n.021
DO - 10.3816/CCC.2001.n.021
M3 - Article
C2 - 12450437
AN - SCOPUS:0035522655
SN - 1533-0028
VL - 1
SP - 187
EP - 188
JO - Clinical Colorectal Cancer
JF - Clinical Colorectal Cancer
IS - 3
ER -